Heparin inhibits phosphorylation and autonomous activity of Ca2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells

American Journal of Pathology

Volumn 161, Issue 5, 2002, Pages 1893-1901

  Mishra Gorur, Ketu ^a   Singer, Harold A ^b   Castellot, John J ^a,c  

^a TUFTS UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALYCULIN; CALYCULIN A; ENZYME INHIBITOR; HEPARIN; OKADAIC ACID; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE (CALCIUM,CALMODULIN) II; TAUTOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; IMMUNOPRECIPITATION; ISOTOPE LABELING; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0036841488     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64465-3     Document Type: Article

References (52)

1. Freedman MD: Pharmacodynamics, clinical indications, and adverse effects of heparin. J Clin Pharmacol 1992, 32:584-596
2. Schoen FJ, Castellot JJ, Jr.: Vascular graft intimal fibrous hyperplasia: Prospects for pharmacological inhibition. J Vasc Surg 1991, 13:758-761
3. Clowes AW, Clowes MM: Regulation of smooth muscle proliferation by heparin in vitro and in vivo. Int Angiol 1987, 6:45-51
4. Castellot JJ, Jr., Cochran DL, Karnovsky MJ: Effect of heparin on vascular smooth muscle cells. I Cell metabolism. J Cell Physiol 1985, 124:21-28
5. Pukac LA, Ottlinger ME, Karnovsky MJ: Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 1992, 267:3707-3711
6. Daum G, Hedin U, Wang Y, Wang T, Clowes AW: Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ Res 1997, 81:17-23
7. Miralem T, Wang A, Whiteside CI, Templeton DM: Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells. J Biol Chem 1996, 271:17100-17106
8. Letourneur D, Caleb BL, Castellot JJ, Jr.: Heparin binding, internalization, and metabolism in vascular smooth muscle cells II. Degradation and secretion in sensitive and resistant cells. J Cell Physiol 1995, 165:687-695
9. Castellot JJ, Jr., Pukac LA, Caleb BL, Wright TC, Jr., Karnovsky MJ: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990, 110: 863]. J Cell Biol 1989, 109:3147-3155
10. Pukac LA, Castellot JJ, Jr., Wright TC, Jr., Caleb BL, Karnovsky MJ: Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul 1990, 1:435-443
11. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL: Competitive, reversible, and potent antagonism of inositol 1,4,5-triphosphate-activated calcium release by heparin. J Biol Chem 1988, 263:11075-11079
12. Kobayashi S, Somlyo AV, Somlyo AP: Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem Biophys Res Commun 1988, 153:625-631
13. 2+ release in smooth muscle: Physiological role of inositol 1,4,5-trisphosphate in pharmacomechanical coupling. J Biol Chem 1989, 264:17997-18004
14. 2+] changes in nucleus and cytosol. Cell Calcium 1994, 16:239-246
15. Roche E, Prentki M: Calcium regulation of immediate-early response genes Cell Calcium 1994, 16:331-338
16. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic smooth muscle cells. Circ Res 1997, 81:575-584
17. Mishra-Gorur K, Castellot JJ: Heparin rapidly and selectively inhibits protein tyrosine phosphorylation in vascular smooth muscle cells. J Cell Physiol 1998, 178:205-215
18. Caleb BL, Hardenbrook M, Cherington PV, Castellot JJ, Jr.: Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. J Cell Physiol 1996, 167:185-195
19. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. J Biol Chem 1996, 271: 2506-2513
20. 2-/calmodulin-dependent protein kinase II. J Biol Chem 1993, 268:14443-14449
21. Hardie DG, Campbell DG, Caudwell FB, Haystead TAJ: Analysis of sites phosphorylated in vivo and vitro. Protein Phosphorylation: A Practical Approach. Edited by Hardie DG. Oxford University Press, 1993, pp 61-84
22. 2+/calmodulin-dependent protein kinase II activation and c-fos induction in mesangial cells. Biochem J 1998, 330:651-657
23. Mishra-Gorur K, Castellot JJ: Heparin rapidly and selectively alters CAMK II phosphorylation in vascular smooth muscle cells. Mol Biol Cell 1997, 8:401a.
24. 2+ (calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem 1986, 261:8581-8584
25. 2+/calmodulin-dependent protein kinase and mutational analysis of its autoregulation. Neuron 1989, 3:59-70
26. Hardingham GE, Chawla S, Johnson CM, Bading H: Distinct functions of nuclear and cytoplasmic calcium and the control of gene expression. Nature 1997, 385:260-264
27. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem 1997, 68:2119-2128
28. Bialojan C, Takai A: Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases: Specificity and kinetics. Biochem J 1988, 256:283-290
29. Cohen P, Holmes CF, Tsukitani Y: Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 1990, 15:98-102
30. Pfeilschifter J, Ochsner M, Whitebread S, De Gasparo M: Down-regulation of protein kinase C potentiates angiotensin II-stimulated phosphoinositide hydrolysis in vascular smooth-muscle cells. Biochem J 1989, 262:285-291
31. 2+/calmodulin-dependent protein kinases. Curr Opin Cell Biol 1993, 5:247-253
32. Tansey MG, Word RA, Hidaka H, Singer HA, Schworer CM, Kamm KE, Stull JT: Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle. J Biol Chem 1992, 267:12511-12516
33. Pauly RR, Bilato C, Sollott SJ, Monticone R, Kelly PT, Lakatta EG, Crow MT: Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 1995, 91:1107-1115
34. Tombes RM, Grant S, Westin EH, Krystal G: G1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMK-II. Cell Growth Differ 1995, 6:1063-1070
35. Lorca T, Cruzaleugi FH, Fesquet D, Cavadore JC, Mery J, Means A, Doree M: Calmodulin-dependent protein kinase II mediates inactivation of the MPF and CSF upon fertilization of Xenopus eggs. Nature 1993, 366:270-273
36. Chao TS, Byron KL, Lee KM, Villereal M, Rosner MR: Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J Biol Chem 1992, 267:19876-19883
37. Bading H, Ginty DD, Greenberg ME: Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993, 260:181-186
38. 2+ in the cell cycle in human fibroblasts: Transitions between G1 and Go and progression into S phase. Mol Biol Cell 1993, 4:293-320
39. Means AR: Calcium, calmodulin and cell cycle regulation. FEBS Lett 1994, 347:1-4
40. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 1991, 181:968-975
41. 2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature 1992, 359:417-420
42. Letourneur D, Caleb BL, Castellot JJ, Jr.: Heparin binding, internalization, and metabolism in vascular smooth muscle cells. I. Upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol 1995, 165:676-686
43. 2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 1986, 83:4253-4257
44. 2+/calmodulin-dependent protein kinase Il by protein phosphatase 2C. J Biol Chem 1993, 268:133-137
45. Mumby MC, Walter G: Protein serine/threonine phosphatases: Structure, regulation and functions in cell growth. Physiol Rev 1993, 73: 673-699
46. DePaoli-Roach AA, Park IK, Cerovsky V, Csortos V, Durbin SD, Kuntz MJ, Sitikov A, Tang PM, Verin A, Zolneirowicz S: Serine/threonine protein phosphatase in the control of cell function. Adv Enzyme Regul 1994, 34:199-224
47. Wera S, Hemmings BA: Serine/threonine protein phosphatases. Biochem J 1995, 311:17-29
48. 2+/ calmodulin-dependent protein kinase II with neuronal cytoskeletal proteins: Characterization of binding to a 190 kDa postsynaptic density protein. J Biol Chem 1995, 270:10043-10049
49. Saitoh Y, Yamamoto H, Fukunaga K, Matsukado Y, Miyamoto E: Inactivation and reactivation of the multifunctional calmodulin-dependent protein kinase brain by autophosphorylation and dephosphorylation: Involvement of protein phosphatases from brain. J Neurochem 1987, 49:1286-1292
50. Seger R, Krebs EG: The MAPK signaling cascade. EMBO J 1995, 9:726-735
51. Morris TA, DeLorenzo RJ, Tombes RM: CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Exp Cell Res 1998, 240:218-227
52. Vadiveloo PK, Filonzi EL, Stanton HR, Hamilton JA: G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis 1997, 133:61-69